Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
AJR. American Journal of Roentgenology|September 24, 2014
Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRIMelvin D'Anastasi, Mike Notohamiprodjo, Gerwin P Schmidt, et al.Investigative Radiology|May 18, 2007
High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative studyGerwin P Schmidt, Bernd Wintersperger, Anno Graser, et al.European Journal of Radiology|December 18, 2007
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CTGerwin P Schmidt, Andrea Baur-Melnyk, Alexander Haug, et al.Journal of Magnetic Resonance Imaging : JMRI|May 13, 2011
Quantitative analysis of vertebral bone marrow perfusion using dynamic contrast-enhanced MRI: initial results in osteoporotic patients with acute vertebral fractureAndreas Biffar, Gerwin P Schmidt, Steven Sourbron, et al.Investigative Radiology|November 24, 2005
High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel systemGerwin P Schmidt, Andrea Baur-Melnyk, Peter Herzog, et al.European Radiology|September 5, 2006
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CTGerwin P Schmidt, Stefan O Schoenberg, Rupert Schmid, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2011
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumorsAlexander R Haug, Axel Rominger, Mona Mustafa, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2010
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumorsAlexander R Haug, Christoph J Auernhammer, Björn Wängler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumorsAlexander R Haug, Ramona Cindea-Drimus, Christoph J Auernhammer, et al.Radiology|September 24, 2013
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CTAlexander R Haug, Ramona Cindea-Drimus, Christoph J Auernhammer, et al.Pageof 3